538964 Stock Overview
Develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Mercury Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹911.45 |
| 52 Week High | ₹1,303.00 |
| 52 Week Low | ₹721.15 |
| Beta | 0.34 |
| 11 Month Change | -3.62% |
| 3 Month Change | -9.06% |
| 1 Year Change | 18.66% |
| 33 Year Change | 47.01% |
| 5 Year Change | 247.88% |
| Change since IPO | 2,705.32% |
Recent News & Updates
Recent updates
Shareholder Returns
| 538964 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.5% | -0.2% | 0.3% |
| 1Y | 18.7% | 40.5% | 27.3% |
Return vs Industry: 538964 underperformed the Indian Pharmaceuticals industry which returned 40.5% over the past year.
Return vs Market: 538964 underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| 538964 volatility | |
|---|---|
| 538964 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 538964's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 538964's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 482 | Rajendra Shah | www.mercurylabs.com |
Mercury Laboratories Limited develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in India and internationally. The company offers analgesic, anti-inflammatory, anti-pyretic, anthelmintic, antibiotic, anti-coagulant, anti-platelet, bleeding agent, anti-fungal, anti-hypertensive, anti-malarial, cardiovascular system, central nervous system, eye, gastro-intestinal system, hypoglycemic/anti-diabetic, multivitamin, protein supplement, respiratory system, anti-allergic, steroids, urinary system, uterine stimulant, and other drugs; and formulations, including tablets, oral liquids, injections, small volume parenterals, and eye/ear drops. It also provides pharmaceutical products for PCOS and uterine disorders, galactagogue, haemostat, iron, pain management, preterm labor management, antiemetic, PPI, vitamin K1, zinc supplement, vitamin D3, digestive enzyme, promolact, and childcare, as well as products for gynec, pediatric, surgeon, and physician applications.
Mercury Laboratories Limited Fundamentals Summary
| 538964 fundamental statistics | |
|---|---|
| Market cap | ₹1.09b |
| Earnings (TTM) | ₹39.89m |
| Revenue (TTM) | ₹692.07m |
27.4x
P/E Ratio1.6x
P/S RatioIs 538964 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 538964 income statement (TTM) | |
|---|---|
| Revenue | ₹692.07m |
| Cost of Revenue | ₹291.31m |
| Gross Profit | ₹400.76m |
| Other Expenses | ₹360.87m |
| Earnings | ₹39.89m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 33.24 |
| Gross Margin | 57.91% |
| Net Profit Margin | 5.76% |
| Debt/Equity Ratio | 5.7% |
How did 538964 perform over the long term?
See historical performance and comparison